ONCSQ (OncoSec Medical) Scaled Net Operating Assets: -0.40 (As of Jan. 2023)


What is OncoSec Medical Scaled Net Operating Assets?

OncoSec Medical ONCSQ -99.00% Scaled Net Operating Assets is -0.40 as of Jan. 2023.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's operating assets for the quarter that ended in Jan. 2023 was $5.19 Mil. OncoSec Medical's operating liabilities for the quarter that ended in Jan. 2023 was $10.89 Mil. OncoSec Medical's Total Assets for the quarter that ended in Oct. 2022 was $14.44 Mil. Therefore, OncoSec Medical's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2023 was -0.40.

OncoSec Medical Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Scaled Net Operating Assets Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.03 0.05 -0.02 0.00

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.00 -0.07 -0.40

ONCSQ vs NOVNQ, USRM, VRTX: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, OncoSec Medical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSec Medical Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Scaled Net Operating Assets falls into.


OncoSec Medical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jul. 2022 )
=(Operating Assets (A: Jul. 2022 )-Operating Liabilities (A: Jul. 2022 ))/Total Assets (A: Jul. 2021 )
=(9.578-9.585)/56.276
=-0.00

where

Operating Assets(A: Jul. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=21.878 - 12.3
=9.578

Operating Liabilities(A: Jul. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=15.76 - 4.127 - 2.048
=9.585

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2023 )
=(Operating Assets (Q: Jan. 2023 )-Operating Liabilities (Q: Jan. 2023 ))/Total Assets (Q: Oct. 2022 )
=(5.188-10.893)/14.439
=-0.40

where

Operating Assets(Q: Jan. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=8.871 - 3.683
=5.188

Operating Liabilities(Q: Jan. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=14.358 - 2.127 - 1.338
=10.893

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.40 mean?
OncoSec Medical (ONCSQ) has a Scaled Net Operating Assets of -0.40 as of Jan. 2023. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Scaled Net Operating Assets too high?
OncoSec Medical's current Scaled Net Operating Assets is -0.40.
How does OncoSec Medical's Scaled Net Operating Assets compare to NOVNQ and USRM?
OncoSec Medical's Scaled Net Operating Assets of -0.40 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Scaled Net Operating Assets is -0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Scaled Net Operating Assets of -0.40. The current Scaled Net Operating Assets is -0.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Scaled Net Operating Assets is -0.40 as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.